Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography

References

• Rajalakshmi R, Behera UC, Bhattacharjee H, et al. Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India. Indian J Ophthalmol. 2020;68(13):21. doi:10.4103/ijo.IJO_21_19
   PubMed Web of Science ®Google Scholar
• Raman R, Vaitheeswaran K, Vinita K, Sharma T. Is prevalence of retinopathy related to the age of onset of diabetes? Sankara nethralaya diabetic retinopathy epidemiology and molecular genetic report no. 5. Ophthalmic Res. 2010. doi:10.1159/000314720
   Web of Science ®Google Scholar
• Romero-Aroca P, Baget-Bernaldiz M, Pareja-Rios A, Lopez-Galvez M, Navarro-Gil R, Verges R. Diabetic macular edema pathophysiology: vasogenic versus inflammatory. J Diabetes Res. 2016;2016:1–17. doi:10.1155/2016/2156273
   Web of Science ®Google Scholar
• Cunha-Vaz J, Bernardes R, Lobo C. Blood-retinal barrier. Eur J Ophthalmol. 2011;21(6_suppl):3–9. doi:10.5301/EJO.2010.6049
   PubMed Web of Science ®Google Scholar
• Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2018. doi:10.1002/14651858.CD007419.pub6
   Web of Science ®Google Scholar
• Kwan CC, Fawzi AA. Imaging and biomarkers in diabetic macular edema and diabetic retinopathy. Curr Diab Rep. 2019;19(10). doi:10.1007/s11892-019-1226-2
   Web of Science ®Google Scholar
• Lee J, Moon BG, Cho AR, Yoon YH. Optical coherence tomography angiography of DME and its association with Anti-VEGF treatment response. Ophthalmology. 2016;123(11):2368–2375. doi:10.1016/j.ophtha.2016.07.010
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Ichio A, Mochida D, et al. Multiple effects of intravitreal aflibercept on microvascular regression in eyes with diabetic macular edema. Ophthalmol Retina. 2019;3(12):1067–1075. doi:10.1016/j.oret.2019.06.005
   Google Scholar
• Choi KE, Yun C, Cha J, Kim SW. OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion. Sci Rep. 2019. doi:10.1038/s41598-019-50637-8
   Web of Science ®Google Scholar
• Agarwal A, Soliman MK, Sepah YJ, Do DV, Nguyen QD. Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics. Pharmgenomics Pers Med. 2014;7:399–409. doi:10.2147/PGPM.S52821
   PubMedGoogle Scholar
• Sadda SR, Campbell J, Dugel PU, et al. Relationship between duration and extent of oedema and visual acuity outcome with ranibizumab in diabetic macular oedema: a post hoc analysis of Protocol I data. Eye. 2019. doi:10.1038/s41433-019-0522-z
   Web of Science ®Google Scholar
• Enders C, Baeuerle F, Lang GE, et al. Comparison between findings in optical coherence tomography angiography and in fluorescein angiography in patients with diabetic retinopathy. Ophthalmologica. 2020;243(1):21–26. doi:10.1159/000499114
   PubMed Web of Science ®Google Scholar
• Moein HR, Novais EA, Rebhun CB, et al. Optical coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema. Retina. 2018;38(12):2277–2284. doi:10.1097/IAE.0000000000001902
   PubMed Web of Science ®Google Scholar
• Dastiridou A, Karathanou K, Riga P, et al. OCT angiography study of the macula in patients with diabetic macular edema treated with intravitreal aflibercept. Ocul Immunol Inflamm. 2019. doi:10.1080/09273948.2019.1704028
   Web of Science ®Google Scholar
• Kozulin P, Natoli R, Bumsted O’Brien KM, Madigan MC, Provis JM. Differential expression of anti-angiogenic factors and guidance genes in the developing macula. Mol Vis. 2009.
   Web of Science ®Google Scholar
• Kozulin P, Provis JM. Differential gene expression in the developing human macula: microarray analysis using rare tissue samples. J Ocul Biol Dis Infor. 2009;2(4):176–189. doi:10.1007/s12177-009-9039-1
   Google Scholar
• Dabir S, Mangalesh S, Kumar KA, Kummelil MK, Sinha Roy A, Shetty R. Variations in the cone packing density with eccentricity in emmetropes. Eye. 2014;28(12):1488–1493. doi:10.1038/eye.2014.229
   Web of Science ®Google Scholar
• Lei J, Durbin MK, Shi Y, et al. Repeatability and reproducibility of superficial macular retinal vessel density measurements using optical coherence tomography angiography en face images. JAMA Ophthalmol. 2017;135(10):1092. doi:10.1001/jamaophthalmol.2017.3431
   PubMed Web of Science ®Google Scholar
• Durbin MK, An L, Shemonski ND, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol. 2017;135(4):370. doi:10.1001/jamaophthalmol.2017.0080
   PubMed Web of Science ®Google Scholar
• Ghasemi Falavarjani K, Iafe NA, Hubschman JP, Tsui I, Sadda SR, Sarraf D. Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion. Investig Ophthalmol Vis Sci. 2017;58(1):30. doi:10.1167/iovs.16-20579
   Web of Science ®Google Scholar
• Hsieh YT, Alam MN, Le D, et al. OCT angiography biomarkers for predicting visual outcomes after ranibizumab treatment for diabetic macular edema. Ophthalmol Retina. 2019;3(10):826–834. doi:10.1016/j.oret.2019.04.027
   Google Scholar
• AttaAllah HR, Mohamed AAM, Ali MA. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography. Int Ophthalmol. 2019;39(8):1845–1859. doi:10.1007/s10792-018-1013-0
   PubMed Web of Science ®Google Scholar
• Wai KM, Singh RP. Changes in macular and peripheral perfusion following anti-vascular endothelial growth factor treatment for patients with diabetic retinopathy. Am J Ophthalmic Clin Trials. 2019;2:4. doi:10.25259/ajoct-3-2019
   Google Scholar
• Sorour OA, Sabrosa AS, Yasin Alibhai A, et al. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy. Int Ophthalmol. 2019;39(10):2361–2371. doi:10.1007/s10792-019-01076-x
   PubMed Web of Science ®Google Scholar
• Fan W, Uji A, Wang K, et al. Severity of diabetic macular edema correlates with retinal vascular bed area on ultra-wide field fluorescein angiography. Retina. 2019. doi:10.1097/iae.0000000000002579
   Web of Science ®Google Scholar
• Michaelides M, Fraser-Bell S, Hamilton R, et al. Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (bolt study): report 1. Retina. 2010;30(5):781–786. doi:10.1097/IAE.0b013e3181d2f145
   PubMed Web of Science ®Google Scholar
• Tomita R, Iwase T, Goto K, Yamamoto K, Ra E, Terasaki H. Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion. Sci Rep. 2019;9(1). doi:10.1038/s41598-019-52732-2
   Web of Science ®Google Scholar
• Karst SG, Deak GG, Gerendas BS, et al. Association of changes in macular perfusion with ranibizumab treatment for diabetic macular edema. JAMA Ophthalmol. 2018;136(4):315. doi:10.1001/jamaophthalmol.2017.6135
   PubMed Web of Science ®Google Scholar
• Klaassen I, Van Noorden CJF, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013;34:19–48. doi:10.1016/j.preteyeres.2013.02.001
   PubMed Web of Science ®Google Scholar
• Trost A, Lange S, Schroedl F, et al. Brain and retinal pericytes: origin, function and role. Front Cell Neurosci. 2016;10. doi:10.3389/fncel.2016.00020
   Web of Science ®Google Scholar
• Ho J, Dans K, You Q, et al. Comparison of 3 mm X 3mm versus 6 mm X 6 mm optical coherence tomography angiography scan sizes in the evaluation of non proliferative diabetic retinopathy. Retina. 2019;39:259–264. doi:10.1097/IAE.0000000000001951
   Web of Science ®Google Scholar
• Rabiolo A, Gelormini F, Marchese A, et al. Macular perfusion parameters in different angiocube sizes: does the size matter in quantitative optical coherence tomography angiography? Invest Ophthalmol Vis Sci. 2018;59:231–237. doi:10.1167/iovs.17-22359
   Web of Science ®Google Scholar
• Elnahry AG, Abdel-Kader AA, Raafat KA, Elrakhawy K. Evaluation of changes in macular perfusion detected by optical coherence tomography angiography following 3 intravitreal monthly bevacizumab injections for diabetic macular edema in the IMPACT study. J Ophthalmol. 2020;2020:5814165. doi:10.1155/2020/5814165
   PubMed Web of Science ®Google Scholar